STOCKWATCH
·
Healthcare Research- Analytics & Technology
Quarterly Result24 Apr 2025, 01:28 am

Syngene Q4 FY25 Results: Revenue from Operations Up 11% YoY to Rs. 1,018 Cr, Full-year Revenue Up 4% to Rs. 3,642 Cr

AI Summary

Syngene International Ltd. announced its Q4 and full-year results for FY25. The company reported a 11% YoY increase in quarterly revenue from operations to Rs. 1,018 Cr and a 4% YoY increase in full-year revenue from operations to Rs. 3,642 Cr. The quarterly operating EBITDA was up by 8% YoY with a margin of 34%. The full-year operating EBITDA was up by 3% YoY with a margin of 29%. The quarterly PAT before exceptional items was down 8% YoY to Rs. 475 Cr. The full-year PAT before exceptional items was down 8% YoY to Rs. 475 Cr. The company has approved exceptional items in FY24 and FY25 related to acquisitions and insurance claims. The company has also reported one-off items in FY24 and FY25 related to tax provisions, interest income, and income tax under the 'Vivad se Vishwas Scheme'.

Key Highlights

  • Q4 revenue from operations crossed Rs. 1,000 Cr mark for the first time
  • Reported revenue from operations up 11% YoY to Rs. 1,018 Cr and up 8% sequentially from the prior quarter
  • Operating EBITDA was up by 8% YoY with operating EBITDA Margin at 34%
  • Full-year revenue from operations up 4% to Rs. 3,642 Cr
  • Operating EBITDA was up by 3% year-on-year with operating EBITDA margin at 29%
SYNGENE
Healthcare Research- Analytics & Technology
Syngene International Ltd

Price Impact